| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $6.12B | +7.9% |
| Cost of Revenue | $3.50B | +8.2% |
| R&D Expense | $317.3M | +8.4% |
| SG&A Expense | $931.1M | +3.2% |
| Operating Income | $1.15B | +16.2% |
| Interest Expense | $59.6M | +2.9% |
| Pre-tax Income | $1.09B | +16.7% |
| Income Tax | $198.8M | +69.6% |
| Net Income | $894.8M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $352.4M | -45.8% |
| Accounts Receivable | $992.4M | +10.1% |
| Inventory | $1.04B | +14.1% |
| Current Assets | $3.06B | +3.8% |
| Total Assets | $15.29B | +7.6% |
| Current Liabilities | $1.86B | +47.4% |
| Long-term Debt | $2.48B | -6.6% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.19B | -0.1% |
| Capital Expenditures | $117.3M | +40.1% |
| Investing Cash Flow | -$937.9M | -352.7% |
| Financing Cash Flow | -$555.2M | +41.3% |
| Free Cash Flow | $1.07B | -3.1% |
| +9.2% |
| EPS (Basic) | $19.12 | +9.7% |
| EPS (Diluted) | $18.88 | +9.7% |
| Total Liabilities |
| $4.77B |
| +2.7% |
| Stockholders' Equity | $10.51B | +10.1% |